The Essential Building Blocks of a Great Life Sciences Investor Presentation
“The Essential Building Blocks of a Great Life Sciences Investor Presentation”
Date: Wednesday, December 20, 2017
Location: Azrieli College for Engineering (26th Shreibom St.), bldg 3 (New Building , the building over the underground parking lot, all the way at the far end of the campus), auditorium C-104 floor -1
with guest speaker:
Founder and CEO, CadenSee (http://www.cadensee.com/)
Chen Sirkis, Founder, CadenSee, will be presenting his latest lecture, “The Essential Building Blocks of a Great Life Sciences Investor Presentation” for the first time, for entrepreneurs and companies in the Life Science and Healthcare sector who want to pitch most effectively to investors.
The talk will present the different parts that life science investors expect to see in a presentation.
An e-book with additional content and helpful links will be coming out soon.
After the lecture, two experienced investors, Jonathan Goldstein, Boston Scientific www.bostonscientific.com and David Waiman will be giving their opinion from an investor’s point of view.
18:00 Registration and Networking
Moderator: Yaron Suissa, CEO, Bio-JLMCity
Greetings: Prof Debbi Shalev, Hd Pharma Engineering, Azrieli College
• “The Essential Building Blocks of a Great Life Sciences Investor Presentation”
Chen Sirkis, Founder and CEO, CadenSee
• Jonathan Goldstein, Director, Corporate R&D and Ventures, Boston Scientific
• David Waimann, director, JBNF and advisor to three venture funds (Our Crowd) and chairman of two UK enterprises
The presentations will all be given in English.
RVSP to reserve your place. We request 20 NIS upon entrance to the event to help cover costs. JLM-BioCity is anon-profit organization composed of volunteers. Your help is real help.
ENTRANCE TO THE AZRIELI COLLEGE OF ENGINEERING WILL ONLY BE FOR PEOPLE WHO HAVE RVSP’ED AND SENT THEIR NAME IN HEBREW AND CAR LICENCE to firstname.lastname@example.org
ABOUT OUR SPEAKERS:
Chen Sirkis, Founder & CEO, CadenSee (Let’s Talk Medical)
After many years of experience in medical marketing, business development, and venture capital, Chen Sirkis established CandenSee, a medical marketing communication and lead generation consulting firm.
CadenSee, helps medical devices and other life science companies tell their stories, convince investors, and get online leads to sales. CadenSee’s objective is to help companies speak effectively to physicians, investors and patients in a voice that can be heard above the noise in the marketplace because it’s clear, relevant and persuasive.
Chen holds an MBA from Tel Aviv University and is a regular speaker at the College of Management and at different forums. Additionally he creates many tools that are available online for free to help life science companies as they grow. His Medical Marketing Communication blog is followed by more than 1200 medical industry professionals.
For more information about Chen, visit his LinkedIn – Profile https://www.linkedin.com/in/chensirkis/
Jonathan Goldstein, Director, Corporate R&D and Ventures, Boston Scientific
Jonathan Goldstein focuses on strategic VC investments in Europe and Israel. He has been working for Boston Scientific Corporation (BSC) since 2012, interfacing with Israeli technology and projects, and generating collaborations across the spectrum of BSC’s R&D, Venture and Business Development functions. Jonathan also manages the Corporate Research Division’s Worldwide Scouting Team, supporting Divisional and Corporate teams in identifying relevant next generation technologies and companies for the company’s pipeline. Jonathan is a member of the Advisory Board of JLM-BioCity. Jonathan holds a BSc. in Chemistry & Biochemistry from Imperial College, London, and an MBA from the University of London.
David Waimann, director, JBNF and advisor to three venture funds (Our Crowd) and chairman of two UK enterprises
David is proud to be one of the directors of the JBNF. Before entering the technological world, he was a development economist working on UN and World Bank projects in Africa. He has since built a number of technological enterprises in the industrial field with three successful exits. For the past 12 years he has been building start-ups in the renewable energy space .
He is an advisor to three venture funds (Our Crowd) and chairman of two UK enterprises including one in the field of medical software.